As of Feb 17
| +0.03 / +0.12%|
The 23 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 28.00, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a +10.28% increase from the last price of 25.39.
The current consensus among 27 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.